NeuroScientific Biopharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
NeuroScientific Biopharmaceuticals has a total shareholder equity of A$3.8M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$3.9M and A$118.0K respectively. NeuroScientific Biopharmaceuticals's EBIT is A$633.4K making its interest coverage ratio -5. It has cash and short-term investments of A$3.3M.
Key information
0%
Debt to equity ratio
AU$0
Debt
Interest coverage ratio | -5x |
Cash | AU$3.34m |
Equity | AU$3.81m |
Total liabilities | AU$118.03k |
Total assets | AU$3.93m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: NSB's short term assets (A$3.5M) exceed its short term liabilities (A$118.0K).
Long Term Liabilities: NSB has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: NSB is debt free.
Reducing Debt: NSB had no debt 5 years ago.
Debt Coverage: NSB has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: NSB has no debt, therefore coverage of interest payments is not a concern.